Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $6.66 billion. The enterprise value is $6.87 billion.
| Market Cap | 6.66B |
| Enterprise Value | 6.87B |
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 141.25 million shares outstanding. The number of shares has increased by 5.89% in one year.
| Current Share Class | 141.25M |
| Shares Outstanding | 141.25M |
| Shares Change (YoY) | +5.89% |
| Shares Change (QoQ) | -0.59% |
| Owned by Insiders (%) | 3.32% |
| Owned by Institutions (%) | 78.24% |
| Float | 122.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.77 |
| Forward PS | 23.08 |
| PB Ratio | 132.41 |
| P/TBV Ratio | 147.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.14, with a Debt / Equity ratio of 27.73.
| Current Ratio | 4.14 |
| Quick Ratio | 3.86 |
| Debt / Equity | 27.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.55 |
Financial Efficiency
Return on equity (ROE) is -258.93% and return on invested capital (ROIC) is -279.69%.
| Return on Equity (ROE) | -258.93% |
| Return on Assets (ROA) | -28.30% |
| Return on Invested Capital (ROIC) | -279.69% |
| Return on Capital Employed (ROCE) | -49.56% |
| Weighted Average Cost of Capital (WACC) | 10.65% |
| Revenue Per Employee | $634,060 |
| Profits Per Employee | -$1.02M |
| Employee Count | 711 |
| Asset Turnover | 0.29 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.61% in the last 52 weeks. The beta is 1.37, so ARWR's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | +13.61% |
| 50-Day Moving Average | 64.10 |
| 200-Day Moving Average | 71.19 |
| Relative Strength Index (RSI) | 23.71 |
| Average Volume (20 Days) | 1,899,753 |
Short Selling Information
The latest short interest is 10.96 million, so 7.76% of the outstanding shares have been sold short.
| Short Interest | 10.96M |
| Short Previous Month | 10.76M |
| Short % of Shares Out | 7.76% |
| Short % of Float | 8.95% |
| Short Ratio (days to cover) | 4.41 |
Income Statement
In the last 12 months, ARWR had revenue of $450.82 million and -$724.21 million in losses. Loss per share was -$5.11.
| Revenue | 450.82M |
| Gross Profit | 449.02M |
| Operating Income | -707.17M |
| Pretax Income | -723.92M |
| Net Income | -724.21M |
| EBITDA | -680.55M |
| EBIT | -707.17M |
| Loss Per Share | -$5.11 |
Balance Sheet
The company has $1.19 billion in cash and $1.40 billion in debt, with a net cash position of -$207.59 million or -$1.47 per share.
| Cash & Cash Equivalents | 1.19B |
| Total Debt | 1.40B |
| Net Cash | -207.59M |
| Net Cash Per Share | -$1.47 |
| Equity (Book Value) | 50.50M |
| Book Value Per Share | 0.36 |
| Working Capital | 977.88M |
Cash Flow
In the last 12 months, operating cash flow was -$271.95 million and capital expenditures -$12.00 million, giving a free cash flow of -$283.94 million.
| Operating Cash Flow | -271.95M |
| Capital Expenditures | -12.00M |
| Depreciation & Amortization | 26.62M |
| Net Borrowing | 578.52M |
| Free Cash Flow | -283.94M |
| FCF Per Share | -$2.01 |
Margins
Gross margin is 99.60%, with operating and profit margins of -156.86% and -160.64%.
| Gross Margin | 99.60% |
| Operating Margin | -156.86% |
| Pretax Margin | -160.58% |
| Profit Margin | -160.64% |
| EBITDA Margin | -150.96% |
| EBIT Margin | -156.86% |
| FCF Margin | n/a |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.89% |
| Shareholder Yield | -5.89% |
| Earnings Yield | -10.84% |
| FCF Yield | -4.26% |
Analyst Forecast
The average price target for ARWR is $106.71, which is 126.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $106.71 |
| Price Target Difference | 126.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 33.20% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |